The invention relates to novel phosphoinositide 3-kinase (PI3K), mammalian target of rapamycin (mTOR) and PI3K-related kinase (PIKKs) inhibitor compounds of formula (I),
Edits on 25 May, 2023
"Remove website redirecting to Patent Public Search front page"